Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: Contribution to dual modulation of vascular tension

Toxicology

Volumn 232, Issue 1-2, 2007, Pages 138-146

  Kubo, Satoko ^a   Doe, Ichiko ^a   Kurokawa, Yuko ^a   Nishikawa, Hiroyuki ^b   Kawabata, Atsufumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b Fuso Pharmaceutical Industries Ltd   (Japan)

Author keywords

Aorta; ATP sensitive K+ channel; Hydrogen sulfide; Nitric oxide synthase; Vascular endothelium

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; HYDROGEN SULFIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHLORIDE; RECOMBINANT ENZYME; SODIUM DERIVATIVE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; COW; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; MALE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; AIR POLLUTANTS; ANIMALS; AORTA; ENZYME INHIBITORS; GLYBURIDE; GUANYLATE CYCLASE; HYDROGEN SULFIDE; MALE; MICE; MUSCLE CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR;

BOVINAE; RATTUS;

EID: 33847128813     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.12.023     Document Type: Article

References (27)

1. Abe K., and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16 3 (1996) 1066-1071
2. Ali M.Y., Ping C.Y., Mok Y.Y., Ling L., Whiteman M., Bhatia M., and Moore P.K. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br. J. Pharmacol. 149 6 (2006) 625-634
3. Beauchamp Jr. R.O., Bus J.S., Popp J.A., Boreiko C.J., and Andjelkovich D.A. A critical review of the literature on hydrogen sulfide toxicity. Crit. Rev. Toxicol. 13 1 (1984) 25-97
4. Bhatia M., Wong F.L., Fu D., Lau H.Y., Moochhala S.M., and Moore P.K. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J. 19 6 (2005) 623-625
5. Bian J.S., Yong Q.C., Pan T.T., Feng Z.N., Ali M.Y., Zhou S., and Moore P.K. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. Pharmacol. Exp. Ther. 316 2 (2006) 670-678
6. Cheng Y., Ndisang J.F., Tang G., Cao K., and Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol. 287 5 (2004) H2316-H2323
7. Distrutti E., Sediari L., Mencarelli A., Renga B., Orlandi S., Antonelli E., Roviezzo F., Morelli A., Cirino G., Wallace J.L., and Fiorucci S. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J. Pharmacol. Exp. Ther. 316 1 (2006) 325-335
8. Dombkowski R.A., Russell M.J., Schulman A.A., Doellman M.M., and Olson K.R. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 1 (2005) R243-R252
9. Fiorucci S., Distrutti E., Cirino G., and Wallace J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131 1 (2006) 259-271
10. Geng B., Chang L., Pan C., Qi Y., Zhao J., Pang Y., Du J., and Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun. 318 3 (2004) 756-763
11. Hosoki R., Matsuki N., and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 237 3 (1997) 527-531
12. Jeong S.O., Pae H.O., Oh G.S., Jeong G.S., Lee B.S., Lee S., Kim du Y., Rhew H.Y., Lee K.M., and Chung H.T. Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 345 3 (2006) 938-944
13. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem. Biophys. Res. Commun. 267 1 (2000) 129-133
14. Lee S.Y., and Lee C.O. Inhibition of Na+-K+ pump and l-type Ca2+ channel by glibenclamide in Guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 312 1 (2005) 61-68
15. Leffler C.W., Parfenova H., Jaggar J.H., and Wang R. Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation. J. Appl. Physiol. 100 3 (2006) 1065-1076
16. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., Anuar F.B., Whiteman M., Salto-Tellez M., and Moore P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 19 9 (2005) 1196-1198
17. Oh G.S., Pae H.O., Lee B.S., Kim B.N., Kim J.M., Kim H.R., Jeon S.B., Jeon W.K., Chae H.J., and Chung H.T. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic. Biol. Med. 41 1 (2006) 106-119
18. Olson K.R. Vascular actions of hydrogen sulfide in nonmammalian vertebrates. Antioxid. Redox. Signal. 7 5-6 (2005) 804-812
19. Qu K., Chen C.P., Halliwell B., Moore P.K., and Wong P.T. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37 3 (2006) 889-893
20. Sheppard D.N., and Robinson K.A. Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line. J. Physiol. 503 Pt 2 (1997) 333-346
21. Stipanuk M.H., and Beck P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 206 2 (1982) 267-277
22. Swaroop M., Bradley K., Ohura T., Tahara T., Roper M.D., Rosenberg L.E., and Kraus J.P. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J. Biol. Chem. 267 16 (1992) 11455-11461
23. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 16 13 (2002) 1792-1798
24. Whiteman M., Li L., Kostetski I., Chu S.H., Siau J.L., Bhatia M., and Moore P.K. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun. 343 1 (2006) 303-310
25. Zhao W., and Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart Circ. Physiol. 283 2 (2002) H474-H480
26. Zhao W., Zhang J., Lu Y., and Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 20 21 (2001) 6008-6016
27. Zhong G., Chen F., Cheng Y., Tang C., and Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J. Hypertens. 21 10 (2003) 1879-1885